Healthcare Archives - Feedback

Healthcare

Ayurveda departments will be opened in all the new 19 AIIMS and approval has been received from the Home Ministry to set up such departments in seven hospitals of the Border Security Force (BSF) and other paramilitary forces, Minister of State for AYUSH Shripad Yesso Naik announced. He said work is already on to start […]

Unichem Laboratories (Unichem), a Rs. 670 crore pharma major, has entered into an agreement to acquire 20% equity stake in the API and intermediate business of Hyderabad based Optimus group (Optimus). The transaction will give Unichem access to Optimus’ US FDA approved API manufacturing facilities, and at the same time, Optimus will gain from the […]

NephroPlus, India’s largest dialysis care network, announced the acquistion of DaVita Care india, part of DaVita Inc, a kidney care provider, says a press release. Under the terms of the agreement, NephroPlus will acquire DaVita Care India’s network of 22 centres which serve more than 1,700 dialysis patients nationwide. With this acquisition, Nephroplus will further […]

Drug firm Strides Pharma Science said it has partnered with funds advised by ICP-III Investment Advisors, which will infuse USD 20 million into its consumer healthcare business. “Board of directors have approved the execution by Strides of definitive agreements with funds advised by ICP-III Investment Advisors (ICP) to provide growth capital and focused attention to […]

The Competition Commission of India (CCI) has given its approval to IHH Healthcare’s acquisition of a controlling stake in Fortis Healthcare, the second largest hospital chain in the country, two people familiar with the development said. An announcement to this effect is expected shortly. Under the deal, the Malaysian company will pick a 31% stake […]

India is leading the global biosimilar pipeline, with the largest number of products launched in the country and emerging economies. Reliance Life Sciences tops the global pecking order, followed by Intas and Biocon. Biosimilars, developed by innovators, are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drugs that are […]

Divis Laboratories, maker of active pharmaceutical ingredients (APIs) and drug intermediates, will spend Rs 15 billion to expand existing facilities over the next 15 months. The company said it would be investing Rs 6 billion each on its Unit-2 at the Vizag SEZ in Andhra and Unit-1 of its Nalgonda SEZ in Telangana. And, another […]

Zydus Wellness and Cadila Healthcare said they were acquiring Heinz India at a valuation of Rs 4,595 crore. Heinz India is the subsidiary of Kraft Heinz and makes Complan and Glucon D.Zydus Wellness chairman Sharvil Patel said on a television channel that the acquisition makes sense given how difficult it is to acquire large brands […]

Novartis has entered into an agreement and plan of merger with Endocyte, a US-based biopharmaceutical company focused on developing targeted therapeutics for cancer treatment. Under the terms of the agreement, Novartis would acquire all outstanding shares of Endocyte common stock for USD 24 per share. This offer values Endocyte’s equity at US$ 2.1 billion.Endocyte uses […]

India’s battle against “superbugs” has got a shot in the arm with the establishment of a bio-repository for resistant microbes, the first of its kind in the country, at the National Centre for Microbial Resource (NCMR) in Pune. The facility last week received the green light from the Department of Biotechnology (DBT) to collect, preserve […]